Somatostatin-containing protein-based drug in the treatment of infertility: efficacy evaluation using a leuprorelin-induced spermatogenesis impairment model in male rats

Introduction. A novel drug based on a somatostatin-containing protein is being developed for use in female and male infertility to increase the reproductive capacity, activate ovarian reserve follicles and their entry into the growth phase, accelerate the growth of resting follicles, increase the volume of ejaculate and improve the sperm quality characteristics.

Objective. To evaluate the efficacy of a somatostatin-containing protein-based drug in a rat model of spermatogenesis disorder induced by a single injection of 600 µg/kg leuprorelin.

Materials & methods. The study evaluated several factors, including microscopic changes in testicular tissue, mass ratios of reproductive organs (testes, epididymis, seminal vesicles), semen parameters, and serum testosterone and somatotropin levels.

Results. It was demonstrated that in the context of gonadotropin reduction and subsequent testosterone decline resulting from prolonged exposure to leuprorelin, the tested preparation, comprising a somatostatin-containing protein in a dosage range of 10 to 250 µg/kg, led to an increase in somatotropin and testosterone levels and the normalization of the spermatogenesis process. It was observed that the studied preparation resulted in a notable elevation in the concentration and proportion of motile spermatozoa.

Conclusion. The obtained results are consistent with previously published data demonstrating improved spermatogenesis parameters following administration of exogenous somatotropic hormone in animal models. This allows us to hypothesize a potential mechanism of action for the tested drug, namely the synthesis of specific autoantibodies against somatostatin and subsequent blockade of its activity, which in turn leads to increased endogenous levels of somatotropic and sex hormones in the organism.

1. Achermann APP, Esteves SC. Clinical Management of Men with Nonobstructive Azoospermia due to Spermatogenic Failure. In: Parekattil S., Esteves S., Agarwal A. (eds.) Male Infertility. Springer, Cham; 2020. DOI: 10.1007/978-3-030-32300-4_23

2. Latif T, Kold Jensen T, Mehlsen J, Holmboe SA, Brinth L, Pors K, Skouby SO, Jørgensen N, Lindahl-Jacobsen R. Semen Quality as a Predictor of Subsequent Morbidity: A Danish Cohort Study of 4,712 Men With Long-Term Follow-up. Am J Epidemiol. 2017;186(8):910-917. DOI: 10.1093/aje/kwx067

3. Zhankina R.A. Muzhskoe besplodie i mezenkhimal’nye stvolovye kletki: est’ li vzaimosvyaz’? Global Science and Innovations: Central Asia. 2021;1(12):13-19. (In Russian). eLIBRARY ID: 46376340

4. Rozhivanov R.V. Stimulyatsiya spermatogeneza gonadotropinami i antiestrogenami pri patozoospermii i besplodii [dissertation]. Moscow; 2019. (In Russian). Accessed April 03, 2025. https://www.endocrincentr.ru/sites/default/files/specialists/science/dissertation/dissertatsia_kravtsova_2020.pdf.

5. Faniev M.V., Shevchenko N.P., Kadyrov Z.A. Modern strategies of infertile male’s treatment with chronical bacterial prostatitis on the stage of preconception predation in protocols of auxiliary reproductive technologies. Andrology and genital surgery. 2017;18(3): 44-53. (In Russian). eLIBRARY ID: 30498695; EDN: ZRKMDH

6. Koc G, Ozdemir AA, Girgin G, Akbal C, Kirac D, Avcilar T, Guney AI. Male infertility in Sertoli cell-only syndrome: An investigation of autosomal gene defects. Int J Urol. 2019;26(2):292-298. DOI: 10.1111/iju.13863

7. Rodprasert W, Virtanen HE, Mäkelä JA, Toppari J. Hypogonadism and Cryptorchidism. Front Endocrinol (Lausanne). 2020;10:906. DOI: 10.3389/fendo.2019.00906

8. Russian patent for invention №2614115/01.08.2016. Bull. №9. Yudin S.M., Lunin V.G. M. Recombinant somatostatin-containing protein, method for production, injecting drug to increase meat and dairy efficiency of agricultural animals, and method for drug application. (In Russian). Accessed April 03, 2025. https://www.elibrary.ru/item.asp?id=38261219 eLIBRARY ID: 38261219; EDN: ZTVFMT

9. Demyashkin G. A. Morfologicheskii analiz spermatogeneza–osnova diagnostiki muzhskogo idiopaticheskogo besplodiya (immunogistokhimicheskii aspekt) [dissertation]. Moscow; 2017. (In Russian). Accessed April 03, 2025. https://www.sechenov.ru/upload/medialibrary/5fd/Avtoreferat.pdf

10. Demyashkin G.A., Philippov E.E. Morphofunctional characteristics of insulin-like growth factor 1 in normal spermatogenesis and in idiopathic infertility. International journal of applied and fundamental research. 2017;(1-2):236-239. (In Russian). eLIBRARY ID: 28385068; EDN: XXDXLV

11. Yao J, Zuo H, Gao J, Wang M, Wang D, Li X. The effects of IGF-1 on mouse spermatogenesis using an organ culture method. Biochem Biophys Res Commun. 2017;491(3):840-847. DOI: 10.1016/j.bbrc.2017.05.125

12. Tenuta M, Carlomagno F, Cangiano B, Kanakis G, Pozza C, Sbardella E, Isidori AM, Krausz C, Gianfrilli D. Somatotropic-Testicular Axis: A crosstalk between GH/IGF-I and gonadal hormones during development, transition, and adult age. Andrology. 2021;9(1):168-184. DOI: 10.1111/andr.12918

13. Xu YM, Hao GM, Gao BL. Application of Growth Hormone in in vitro Fertilization. Front Endocrinol (Lausanne). 2019;10:502. DOI: 10.3389/fendo.2019.00502

14. Hart RJ, Rombauts L, Norman RJ. Growth hormone in IVF cycles: any hope? Curr Opin Obstet Gynecol. 2017;29(3):119-125. DOI: 10.1097/GCO.0000000000000360

15. Ohyama K, Iwatani N, Nakagomi Y, Ohta M, Shimura Y, Sano T, Sato K, Ohno R, Mabe H, Ishikawa H, Nakazawa S. Growth hormone advances spermatogenesis in premature rats treated with gonadotropin-releasing hormone agonist. Endocr J. 1999;46(4):555-562. DOI: 10.1507/endocrj.46.555

16. Zueva A.A., Kryshen K.L., Matichin A.A., Kargopolceva D.R., Katelnikova A.E., Trofimets E.I., Demyanovskiy M.N. , Vaganova D.S., Gajdaj D.S. Approbation of transrectal electroejaculation technique for rats. Laboratory Animals for Science. 2019;(3). (In Russian). DOI: 10.29296/2618723X-2019-03-07

17. Koptyaeva K., Muzhikyan A., Gushchin Ya., Belyaeva E., Makarova M., Makarov V. Some Features Of Fixation Of Organs And Tissues Of Laboratory Animals For Quality Of Gistological Analysis. Laboratory Animals for Science. 2018;(2). (In Russian). DOI: 10.29296/2618723X-2018-02-07

18. Jia YF, Feng Q, Ge ZY, Guo Y, Zhou F, Zhang KS, Wang XW, Lu WH, Liang XW, Gu YQ. Obesity impairs male fertility through long-term effects on spermatogenesis. BMC Urol. 2018;18(1):42. DOI: 10.1186/s12894-018-0360-5

19. Matichin A.A., Faustova N.M., Kargopolceva D.R., Makarova M.N. Circadian fluctuation in plasma testosterone levels in adult male rats. Laboratory Animals for Science. 2020;2. (In Russian). DOI: 10.29296/2618723X-2020-02-04